INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 135 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,234 | +116.7% | 62,298 | +148.7% | 0.00% | +200.0% |
| Q2 2023 | $11,185 | -48.5% | 25,049 | -5.5% | 0.00% | -50.0% |
| Q1 2023 | $21,736 | -49.1% | 26,508 | -3.2% | 0.00% | -60.0% |
| Q4 2022 | $42,711 | -99.9% | 27,379 | -2.8% | 0.01% | -16.7% |
| Q3 2022 | $48,602,000 | -6.3% | 28,175 | -6.0% | 0.01% | 0.0% |
| Q2 2022 | $51,878,000 | +61659.5% | 29,987 | +28.3% | 0.01% | -25.0% |
| Q1 2022 | $84,000 | -32.8% | 23,374 | -6.6% | 0.01% | -11.1% |
| Q4 2021 | $125,000 | -32.1% | 25,030 | -2.6% | 0.01% | -35.7% |
| Q3 2021 | $184,000 | -25.8% | 25,686 | -4.1% | 0.01% | -22.2% |
| Q2 2021 | $248,000 | +22.8% | 26,778 | +23.1% | 0.02% | +12.5% |
| Q1 2021 | $202,000 | – | 21,746 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |